DEA proposes hiking Schedule I drug production for medical research

Mugglehead
By Natalia Buendia CalvilloOct 18, 2021, 5:57 pm458 ptsTop
The United States Drug Enforcement Administration (DEA) has proposed significantly increasing production quotas for synthesizing, extracting and manufacturing schedule I drugs including MDMA, LSD, psilocybin and cannabis. Just last month, the agency raised production quotas for the substances, but now it’s…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.